Table 1 Major clinicopathological features of 50 PMP patients
Items | Value |
|---|---|
Sex, n (%) | |
Male | 27 (54.0) |
Female | 23 (46.0) |
Age (years), median (range) | 55 (31 - 76) |
BMI (kg/m2), median (range) | 22.0 (15.9 - 27.8) |
KPS score, median (range) | 90 (60 - 100) |
Operation History, n (%) | |
No | 7 (14.0) |
Yes | 43 (86.0) |
History of intravenous chemotherapy, n (%) | |
No | 27 (54.0) |
Yes | 23 (46.0) |
History of intraperitoneal chemotherapy, n (%) | |
No | 27 (54.0) |
Yes | 23 (46.0) |
Preoperative CEA, n (%) | |
Normal | 9 (18.0) |
Increased | 41 (82.0) |
Preoperative CA19-9, n (%) | |
Normal | 22 (44.0) |
Increased | 28 (56.0) |
Preoperative CA125, n (%) | |
Normal | 22 (44.0) |
Increased | 28 (56.0) |
Histopathological type, n (%) | |
LG-PMP | 25 (50.0) |
HG-PMP | 25 (50.0) |
PCI score, median (range) | 36 (3 - 39) |
CC score | |
0 - 1 | 18 (36.0) |
2 - 3 | 32 (64.0) |